CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Zolpidem tartrate

Last Updated: March 7, 2013
Result type: Reports
Project Number: SR0314
Product Line: Common Drug Review

Generic Name: Zolpidem tartrate

Brand Name: Sublinox

Manufacturer: Meda Valeant Pharma Canada Inc.

Indications: Insomnia, short-term treatment

Submission Type: New

Project Status: Complete

Date Recommendation Issued: September 25, 2013

Recommendation Type: Do not list